Alignment Healthcare (ALHC) Stock Forecast & Price Target

Q: What is ALHC’s average 12-month price target, according to analysts?

Based on analyst ratings, Alignment Healthcare’s 12-month average price target is 25.14.

Q: What is ALHC’s upside potential, based on the analysts’ average price target?

Alignment Healthcare has 47.97% upside potential, based on the analysts’ average price target.

Q: Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

Q: How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Q: Is ALHC a Buy, Sell or Hold?

Alignment Healthcare has a consensus rating of Strong Buy which is based on 6 buy ratings, 2 hold ratings and 0 sell ratings.

Q: What is Alignment Healthcare’s price target?

The average price target for Alignment Healthcare is 25.14. This is based on 8 Wall Streets Analysts 12-month price targets, issued in the past 3 months. The highest analyst price target is $30.00 ,the lowest forecast is $18.00. The average price target represents 47.97% Increase from the current price of $16.99.

Q: What do analysts say about Alignment Healthcare?

Alignment Healthcare’s analyst rating consensus is a Strong Buy. This is based on the ratings of 8 Wall Streets Analysts.

Q: How can I buy shares of ALHC?

Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.

Compare

171 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

ALHC Analyst Ratings

Strong Buy

6 Buy

2 Hold

0 Sell

Based on 8 analysts giving stock ratings to

Alignment

Healthcare

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

ALHC Stock 12 Month Forecast

Average Price Target

$25.14

▲(47.97% Upside)

Based on 8 Wall Street analysts offering 12 month price targets for Alignment Healthcare in the last 3 months. The average price target is $25.14 with a high forecast of $30.00 and a low forecast of $18.00. The average price target represents a 47.97% change from the last price of $16.99.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"11":"$11","16":"$16","21":"$21","26":"$26","31":"$31"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":30,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$30.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":25.14,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$25.14</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":18,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$18.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[11,16,21,26,31],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Jun<br/>2025","6":"Sep<br/>2025","9":"Dec<br/>2025","12":"Mar<br/>2026","25":"Mar<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,19.65,20.446153846153845,21.24230769230769,22.038461538461537,22.834615384615383,23.63076923076923,24.426923076923075,25.223076923076924,26.019230769230766,26.815384615384616,27.61153846153846,28.407692307692308,29.203846153846154,{"y":30,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,19.65,20.072307692307692,20.494615384615383,20.916923076923077,21.339230769230767,21.76153846153846,22.183846153846154,22.606153846153845,23.02846153846154,23.450769230769232,23.873076923076923,24.295384615384616,24.717692307692307,{"y":25.14,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,19.65,19.52307692307692,19.396153846153844,19.269230769230766,19.142307692307693,19.015384615384615,18.888461538461538,18.76153846153846,18.634615384615383,18.507692307692306,18.380769230769232,18.253846153846155,18.126923076923077,{"y":18,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":15.69,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":18.08,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":16.77,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":15.51,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":14.21,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 14, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":12.97,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 16, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":16.64,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 16, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":16.82,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 20, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":16.86,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 22, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":19.08,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 23, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":19.75,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 31, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":22.65,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 19,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 29, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":19.65,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 18,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 29, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target$30.00

Average Price Target$25.14

Lowest Price Target$18.00

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

Jessica Tassan

Piper Sandler

$30

Buy

76.57%

Upside

Reiterated

03/02/26

Piper Sandler Sticks to Its Buy Rating for Alignment Healthcare (ALHC)

Andrew Mok CFA

Barclays

$18

Hold

5.94%

Upside

Reiterated

02/27/26

Barclays Reaffirms Their Hold Rating on Alignment Healthcare (ALHC)

Ryan Langston

TD Cowen

$25

Buy

47.15%

Upside

Reiterated

02/27/26

Alignment Healthcare: Conservative Guidance, Solid EBITDA Trajectory, and Limited Regulatory Risk Support Buy Rating and $25 Target

Ryan Daniels

William Blair

―

Buy

―

Reiterated

02/26/26

Analysts Offer Insights on Healthcare Companies: Alignment Healthcare (NASDAQ: ALHC), Butterfly Network (NYSE: BFLY) and Neurogene (NASDAQ: NGNE)

John Stansel

J.P. Morgan

$26

Buy

53.03%

Upside

Reiterated

02/05/26

J.P. Morgan Keeps Their Buy Rating on Alignment Healthcare (ALHC)

Michael Ha

Robert W. Baird

$22→$28

Buy

64.80%

Upside

Reiterated

01/30/26

Alignment Healthcare price target raised to $28 from $22 at BairdAlignment Healthcare price target raised to $28 from $22 at Baird

Matthew Gillmor CFA

KeyBanc

$21→$28

Buy

64.80%

Upside

Reiterated

01/22/26

Analysts Are Bullish on These Healthcare Stocks: Invivyd (IVVD), Alignment Healthcare (ALHC)

Jonathan Yong

UBS

$18→$21

Hold

23.60%

Upside

Reiterated

01/14/26

Alignment Healthcare price target raised to $21 from $18 at UBSAlignment Healthcare price target raised to $21 from $18 at UBS

Scott Fidel

Goldman Sachs

$22→$24

Buy

41.26%

Upside

Reiterated

12/03/25

Alignment Healthcare (ALHC) Gets a Buy from Goldman Sachs

Kevin Fischbeck

Bank of America Securities

$23

Buy

35.37%

Upside

Reiterated

09/09/25

Alignment Healthcare's Strong Star Ratings and Growth Potential Drive Buy Rating

Whit Mayo

Leerink Partners

$20

Buy

17.72%

Upside

Reiterated

09/09/25

Analysts Have Conflicting Sentiments on These Healthcare Companies: Bioxcel Therapeutics (NASDAQ: BTAI) and Alignment Healthcare (NASDAQ: ALHC)

Analyst Type

Any

Human Analysts

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

Jessica Tassan

Piper Sandler

$30

Buy

76.57%

Upside

Reiterated

03/02/26

Piper Sandler Sticks to Its Buy Rating for Alignment Healthcare (ALHC)

Andrew Mok CFA

Barclays

$18

Hold

5.94%

Upside

Reiterated

02/27/26

Barclays Reaffirms Their Hold Rating on Alignment Healthcare (ALHC)

Ryan Langston

TD Cowen

$25

Buy

47.15%

Upside

Reiterated

02/27/26

Alignment Healthcare: Conservative Guidance, Solid EBITDA Trajectory, and Limited Regulatory Risk Support Buy Rating and $25 Target

Ryan Daniels

William Blair

―

Buy

―

Reiterated

02/26/26

Analysts Offer Insights on Healthcare Companies: Alignment Healthcare (NASDAQ: ALHC), Butterfly Network (NYSE: BFLY) and Neurogene (NASDAQ: NGNE)

John Stansel

J.P. Morgan

$26

Buy

53.03%

Upside

Reiterated

02/05/26

J.P. Morgan Keeps Their Buy Rating on Alignment Healthcare (ALHC)

Michael Ha

Robert W. Baird

$22→$28

Buy

64.80%

Upside

Reiterated

01/30/26

Alignment Healthcare price target raised to $28 from $22 at BairdAlignment Healthcare price target raised to $28 from $22 at Baird

Matthew Gillmor CFA

KeyBanc

$21→$28

Buy

64.80%

Upside

Reiterated

01/22/26

Analysts Are Bullish on These Healthcare Stocks: Invivyd (IVVD), Alignment Healthcare (ALHC)

Jonathan Yong

UBS

$18→$21

Hold

23.60%

Upside

Reiterated

01/14/26

Alignment Healthcare price target raised to $21 from $18 at UBSAlignment Healthcare price target raised to $21 from $18 at UBS

Scott Fidel

Goldman Sachs

$22→$24

Buy

41.26%

Upside

Reiterated

12/03/25

Alignment Healthcare (ALHC) Gets a Buy from Goldman Sachs

Kevin Fischbeck

Bank of America Securities

$23

Buy

35.37%

Upside

Reiterated

09/09/25

Alignment Healthcare's Strong Star Ratings and Growth Potential Drive Buy Rating

Whit Mayo

Leerink Partners

$20

Buy

17.72%

Upside

Reiterated

09/09/25

Analysts Have Conflicting Sentiments on These Healthcare Companies: Bioxcel Therapeutics (NASDAQ: BTAI) and Alignment Healthcare (NASDAQ: ALHC)

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

xxx

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Alignment Healthcare

3 Months

xxx

Success Rate

9/16 ratings generated profit

Average Return

+8.04%

reiterated a xxx

rating 6 months ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 3 Months would result in 56.25% of your transactions generating a profit, with an average return of +8.04% per trade.

1 Year

Ryan LangstonTD Cowen

Success Rate

6/8 ratings generated profit

Average Return

+14.10%

reiterated a buy rating 18 days ago

Copying Ryan Langston's trades and holding each position for 1 Year would result in 75.00% of your transactions generating a profit, with an average return of +14.10% per trade.

2 Years

xxx

Success Rate

13/16 ratings generated profit

Average Return

+56.18%

reiterated a xxx

rating 6 months ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 2 Years would result in 81.25% of your transactions generating a profit, with an average return of +56.18% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

ALHC Analyst Recommendation Trends

Rating

Nov 25

Dec 25

Jan 26

Feb 26

Mar 26

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, ALHC has received 18 Buy Ratings, 29 Hold Ratings, and 0 Sell Ratings. ALHC average Analyst price target in the past 3 months is 25.14.

Each month's total comprises the sum of three months' worth of ratings.

ALHC Financial Forecast

ALHC Earnings Forecast

Next quarter’s earnings estimate for ALHC is <$0.01 with a range of -$0.01 to $0.02. The previous quarter’s EPS was -$0.05. ALHC beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.43% of the time in the same period. In the last calendar year ALHC has Performed in-line its overall industry.

ALHC Sales Forecast

Next quarter’s sales forecast for ALHC is $1.22B with a range of $1.21B to $1.23B. The previous quarter’s sales results were $1.01B. ALHC beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 49.17% of the time in the same period. In the last calendar year ALHC has Performed in-line its overall industry.

ALHC Stock Forecast FAQ

What is ALHC’s average 12-month price target, according to analysts?

Based on analyst ratings, Alignment Healthcare’s 12-month average price target is 25.14.

What is ALHC’s upside potential, based on the analysts’ average price target?

Alignment Healthcare has 47.97% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is ALHC a Buy, Sell or Hold?

Alignment Healthcare has a consensus rating of Strong Buy which is based on 6 buy ratings, 2 hold ratings and 0 sell ratings.

What is Alignment Healthcare’s price target?

The average price target for Alignment Healthcare is 25.14. This is based on 8 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $30.00 ,the lowest forecast is $18.00. The average price target represents 47.97% Increase from the current price of $16.99.

What do analysts say about Alignment Healthcare?

Alignment Healthcare’s analyst rating consensus is a Strong Buy. This is based on the ratings of 8 Wall Streets Analysts.

How can I buy shares of ALHC?

Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.

Alignment Healthcare (ALHC) Stock Forecast & Price Target

ALHC Analyst Ratings

ALHC Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering Alignment Healthcare

ALHC Analyst Recommendation Trends

ALHC Financial Forecast

ALHC Earnings Forecast

ALHC Sales Forecast

ALHC Stock Forecast FAQ

Detailed List of Analyst Forecasts